Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 60.30
+4.85 (8.75%)
Mar 27, 2026, 4:00 PM EDT
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 7.93 billion as of March 27, 2026. Its market cap has increased by 73.51% in one year.
Market Cap
7.93B
Enterprise Value
7.72B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
60.30
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 7.93B, an increase of 80.20%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 7.93B | 6.91% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 9.20B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.98B |
| Sino Biological,Inc. | 8.58B |
| Daan Gene | 8.14B |
| Zhejiang Ausun Pharmaceutical | 8.11B |
| Youcare Pharmaceutical Group | 7.85B |
| Nanjing Vazyme Biotech | 7.72B |
| Suzhou Fengbei Biotech Stock | 7.50B |